Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Gilhus

Showing results (41-50 of 173) with videos related to

Pageof 18
Sort By:
Acta Neurologica Scandinavica|July 1, 1987
CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?J A Aarli, N E Gilhus, H Hofstad
Acta Neurologica Scandinavica|January 13, 2005
Myasthenia gravis: clinical, immunological, and therapeutic advancesF Romi, N E Gilhus, J A Aarli
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 10, 1990
[Myasthenia gravis and thymoma]B Gundersen, N E Gilhus, J A Aarli
International Journal of Immunopharmacology|January 1, 1982
HLA antigens in epileptic patients with drug-induced immunodeficiencyN E Gilhus, J A Aarli, E Thorsby
European Journal of Neurology|May 1, 2001
Task force on minimum standards for health care of people with multiple sclerosis: June 1999M P Barnes, N E Gilhus, M Wender, et al.
Acta Neurologica Scandinavica|October 1, 1990
Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravisC A Vedeler, N E Gilhus, R Matre
Neurology|February 1, 1984
Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodiesN E Gilhus, J A Aarli, R Matre
Journal of Neuroimmunology|December 1, 1983
Myasthenia gravis. Antibodies to skeletal muscle cell surface antigensN E Gilhus, J A Aarli, R Matre
European Journal of Neurology|June 2, 2007
Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical featuresF Romi, J A Aarli, N E Gilhus
Autoimmunity|January 1, 1992
Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disordersJ A Aarli, N E Gilhus, R Matre
Pageof 18

Showing results (41-50 of 173) with videos related to

Sort By:
Pageof 18
Acta Neurologica Scandinavica|July 1, 1987
CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?J A Aarli, N E Gilhus, H Hofstad
Acta Neurologica Scandinavica|January 13, 2005
Myasthenia gravis: clinical, immunological, and therapeutic advancesF Romi, N E Gilhus, J A Aarli
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 10, 1990
[Myasthenia gravis and thymoma]B Gundersen, N E Gilhus, J A Aarli
International Journal of Immunopharmacology|January 1, 1982
HLA antigens in epileptic patients with drug-induced immunodeficiencyN E Gilhus, J A Aarli, E Thorsby
European Journal of Neurology|May 1, 2001
Task force on minimum standards for health care of people with multiple sclerosis: June 1999M P Barnes, N E Gilhus, M Wender, et al.
Acta Neurologica Scandinavica|October 1, 1990
Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravisC A Vedeler, N E Gilhus, R Matre
Neurology|February 1, 1984
Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodiesN E Gilhus, J A Aarli, R Matre
Journal of Neuroimmunology|December 1, 1983
Myasthenia gravis. Antibodies to skeletal muscle cell surface antigensN E Gilhus, J A Aarli, R Matre
European Journal of Neurology|June 2, 2007
Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical featuresF Romi, J A Aarli, N E Gilhus
Autoimmunity|January 1, 1992
Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disordersJ A Aarli, N E Gilhus, R Matre
Pageof 18